本页面由Tiger Trade Technology Pte. Ltd.提供服务

Marinus Pharmaceuticals

0.5500
0.0000
成交量:- -
成交额:60.56万
市值:3,035.21万
市盈率:-0.22
高:0.5500
开:0.5500
低:0.5500
收:0.5500
52周最高:10.50
52周最低:0.2202
股本:5,518.56万
流通股本:3,451.52万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.4662
每股收益(LYR):-2.6310
净资产收益率:-2986.55%
总资产收益率:-57.97%
市净率:-0.45
市盈率(LYR):-0.21

数据加载中...

2024/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/04

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/28

重要事件披露

Form 8-K - Current report
2023/09/19

重要事件披露

Form 8-K - Current report
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/15

重要事件披露

Form 8-K - Current report